Supernus pauses new patient starts for Parkinson's pump Onapgo, citing high demand
5th November 2025 Uncategorised 0Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that patients’ appetite for the wearable is more than it can currently handle.
More: Supernus pauses new patient starts for Parkinson's pump Onapgo, citing high demand
Source: fierce